Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Research
Tenaya's cardiac gene therapy boosts long-term survival in mice
Tenaya Therapeutics’ gene therapy for an inherited heart condition that can cause sudden death appears to be effective in mice, new data show.
Helen Floersh
Mar 18, 2024 2:33pm
Astellas puts the cork back in $350M Xork deal with Cartesian
Mar 14, 2024 10:41am
CAR-T for brain cancer extends survival in phase 1 trial
Mar 12, 2024 9:00am
VC investment in biopharma dropped nearly $7B in 2023: PitchBook
Mar 5, 2024 5:00am
BioCardia rejigs phase 3 heart failure data to find a path
Mar 4, 2024 10:15am
FDA lifts hold on Iovance's lung cancer cell therapy trial
Mar 4, 2024 9:44am
More News
Epigenetic silencing lasts in mice, Chroma-sponsored study shows
Feb 28, 2024 11:00am
Ginkgo-a-go-go! Bioworks company forges 3 acquisition deals
Feb 28, 2024 10:10am
J&J to close Bay Area R&D site less than 18 months after opening
Feb 25, 2024 6:43pm
Astellas bets more than $800M on Kelonia's delivery tech
Feb 15, 2024 6:30pm
See more stories